 Aim 3: Quantify macrophage-mediated localized and systemic inflammation by measuring M1M2-related inflammatory cytokines in adipose tissue and peripheral blood after 4 and 12 weeks administration of liraglutide versus placebo to obese, type 2 diabetic patients. 